{
  "variant_id": {
    "Gene": "BRCA2",
    "Protein_Change": {
      "ref": "R",
      "alt": "W",
      "position": "165"
    },
    "variant_string_id": "BRCA2 R165W"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The disease mechanism involves loss of function of BRCA2, leading to defects in homologous recombination repair and cancer susceptibility.",
      "judgment": "Yes",
      "reasoning": "The papers explicitly define the molecular basis of BRCA2 function."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "Enzyme activity assays, cell-based assays, and structural studies are used to assess the functional impact of R165W.",
      "judgment": "Yes",
      "reasoning": "These assays directly model the disease mechanism."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "Basic controls (WT and known pathogenic variants) and replicates are included in some papers. Known pathogenic variants are used as positive controls.",
      "judgment": "Yes",
      "reasoning": "Basic controls and variant controls are present."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "Statistical analyses are insufficient for OddsPath calculation, but multiple pathogenic controls were used.",
      "judgment": "Yes",
      "reasoning": "Sufficient control variants support the classification."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_moderate"
  },
  "overall_conclusion": "The BRCA2 R165W variant is supported by moderate functional evidence as pathogenic based on enzyme activity assays, cell-based studies, and structural analyses."
}